ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Analyst Ratings and Target Price Adjustments: Roblox, Walmart, Nike, Starbucks…

Bruno T
Analysis & Opinion
May 14 2024 7:28AM

Roblox Corporation saw a notable adjustment by ROTH MKM, which downgraded the company’s stock from “buy” to “neutral,” significantly reducing the price target from USD 55 to USD 35. This revision suggests a tempered outlook on the company’s near-term growth prospects.

Expedia Group, Inc. maintains a “hold” rating from Melius Research LLC, though the firm has lowered its price target from USD 157 to USD 125, indicating potential concerns over the travel industry’s recovery trajectory.

Mettler-Toledo International, Inc. received a positive adjustment from Zacks, maintaining a “neutral” recommendation but raising the price target from USD 1313 to USD 1586. This increase reflects higher confidence in the company’s market position and financial health.

Nike, Inc. continues to be favored by CICC with an “outperform” rating, although the target price has been adjusted down from USD 137.46 to USD 109.78, possibly due to challenges in the retail sector.

Starbucks Corporation also holds an “outperform” recommendation from Wolfe Research, with a reduced target price from USD 109 to USD 85, likely influenced by current economic conditions affecting consumer discretionary spending.

Walmart Inc. retains its “outperform” rating from Baird, despite a dramatic cut in the target price from USD 195 to USD 65, suggesting significant reassessment of the retail giant’s short-term earnings potential and market conditions.

Deckers Outdoor Corporation has received an “outperform” initiation from CICC at a target price of USD 1002.17, indicating strong confidence in the company’s growth potential in the outdoor apparel and footwear market.

Crh Plc was newly rated by RBC Capital with an “outperform” recommendation and a target price of USD 110, reflecting optimism about the construction materials company’s market expansion and financial performance.

Moderna, Inc., known for its mRNA technology and vaccines, was initiated with an “in-line” recommendation by Evercore ISI, with a target price set at USD 120, aligning with the industry’s ongoing developments and challenges.

Your Recent History